Surgical treatment of recurrent endometrial carcinoma (Q75202712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

title

Surgical treatment of recurrent endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

main subject

endometrial carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Elio Campagnutta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Giovanni De Piero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Francesco Sopracordevole

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

M Caterina Visentin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Luca Martella

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Carlo Scarabelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

page(s)

89-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

Risk factors and recurrent patterns in Stage I endometrial cancer.

16 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

Isolated vaginal recurrences of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Treatment of vaginal recurrence in endometrial cancer. A review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Isolated vaginal recurrences of endometrial adenocarcinoma and their management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Isolated Vaginal Recurrences in Endometrial Carcinoma: Treatment Results Using High-Dose-Rate Intracavitary Brachytherapy and External Beam Radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration 1947-1963.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Pelvic exenteration for recurrent endometrial cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Dactinomycin in the treatment of recurrent or persistent endometrial carcinoma: A Phase II study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Radiation therapy for endometrial cancer in patients treated for postoperative recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

The Role of Surgical Cytoreduction in Stage IV Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Hematogenous dissemination in corpus cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11868

7 January 2021

Identifiers

DOI

10.1002/CNCR.11868

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14692028%20AND%20SRC:MED&resulttype=core&format=json